Chemoinformaics analysis of (1S,2R,5R)-5-METHYL-2-PROPAN-2-YLCYCLOHEXAN-1-OL
| Molecular Weight | 156.269 | nRot | 1 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 6 |
| Exact Molecular Weight | 156.151 | nRing | 1 |
| Solubility: LogS | -2.73 | nHRing | 0 |
| Solubility: LogP | 3.022 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 30.8379 |
| nHD | 1 | BPOL | 20.0641 |
| QED | 0.618 |
| Synth | 3.353 |
| Natural Product Likeliness | 1.864 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.04 |
| HIA | 0.005 |
| CACO-2 | -4.323 |
| MDCK | 0.0000273 |
| BBB | 0.832 |
| PPB | 0.822564 |
| VDSS | 1.132 |
| FU | 0.12294 |
| CYP1A2-inh | 0.25 |
| CYP1A2-sub | 0.707 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.855 |
| CYP2c9-inh | 0.108 |
| CYP2c9-sub | 0.895 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.373 |
| CYP3a4-inh | 0.023 |
| CYP3a4-sub | 0.307 |
| CL | 14.327 |
| T12 | 0.354 |
| hERG | 0.026 |
| Ames | 0.02 |
| ROA | 0.039 |
| SkinSen | 0.281 |
| Carcinogencity | 0.083 |
| EI | 0.939 |
| Respiratory | 0.293 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.905283 |